Unknown

Dataset Information

0

Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency).

ABSTRACT: Arts syndrome or phosphoribosyl-pyrophosphate-synthetase-1 (PRPS1) deficiency is caused by loss-of-function mutations in the PRPS1 gene (Xq22.3). PRPS1 is an initial and essential step for the synthesis of the nucleotides of purines, pyrimidines, and nicotinamide. Classically, affected males present with sensorineural hearing loss, optic atrophy, muscular hypotonia, developmental impairment, and recurrent severe respiratory infections early in life. Treatment of a 3-year old boy with S-adenosylmethionine (SAM) replenished erythrocyte purine nucleotides of adenosine and guanosine, while SAM and nicotinamide riboside co-therapy further improved his clinical phenotype as well as T-cell survival and function.

SUBMITTER: Lenherr N 

PROVIDER: S-EPMC7823043 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency).

Lenherr Nina N   Christodoulou John J   Duley John J   Dobritzsch Doreen D   Fairbanks Lynette L   Datta Alexandre N AN   Filges Isabel I   Gürtler Nicolas N   Roelofsen Jeroen J   van Kuilenburg André B P ABP   Kemper Claudia C   West Erin E EE   Szinnai Gabor G   Huemer Martina M  

Molecular genetics and metabolism reports 20210120

Arts syndrome or phosphoribosyl-pyrophosphate-synthetase-1 (PRPS1) deficiency is caused by loss-of-function mutations in the <i>PRPS1</i> gene (Xq22.3). PRPS1 is an initial and essential step for the synthesis of the nucleotides of purines, pyrimidines, and nicotinamide. Classically, affected males present with sensorineural hearing loss, optic atrophy, muscular hypotonia, developmental impairment, and recurrent severe respiratory infections early in life. Treatment of a 3-year old boy with S-ad  ...[more]

Similar Datasets

Unknown Arts syndrome is caused by loss-of-function mutations in PRPS1.
| S-EPMC1950830 | biostudies-literature
Unknown Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia.
| S-EPMC9291897 | biostudies-literature
Unknown Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
| S-EPMC5518663 | biostudies-literature
Unknown Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD<sup>+</sup> by Generating Dihydronicotinamide Riboside.
| S-EPMC9269339 | biostudies-literature
Unknown Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.
| S-EPMC6770226 | biostudies-literature
Unknown Chemo-enzymatic synthesis of isotopically labeled nicotinamide riboside.
| S-EPMC6054311 | biostudies-literature
Unknown Atypical presentation of Arts syndrome due to a novel hemizygous loss-of-function variant in the <i>PRPS1</i> gene.
| S-EPMC7689168 | biostudies-literature
Unknown NAD<sup>+</sup> augmentation with nicotinamide riboside improves lymphoid potential of Atm<sup>-/-</sup> and old mice HSCs.
| S-EPMC8455618 | biostudies-literature
Unknown Nicotinamide riboside kinase structures reveal new pathways to NAD+.
| S-EPMC1994991 | biostudies-literature
Unknown New Crystalline Salts of Nicotinamide Riboside as Food Additives.
| S-EPMC8125264 | biostudies-literature